Thomas John Dietz, Director at Paratek Pharmaceuticals, Inc. (PRTK), sold 9,330 shares at $5.01 ($47K) on 2018-12-21, disclosed to the SEC on 2018-12-26.
Open-market sale of $47k PRTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EIGR | SELL | 2022-12-27 | $26K | — | Filing → |
| EIGR | BUY | 2021-04-12 | $21K | — | Filing → |
| EIGR | BUY | 2020-03-17 | $5K | — | Filing → |